ARTICLE | Company News
Alizyme licenses ATL-101 from KU Leuven
March 6, 2000 8:00 AM UTC
Alizyme (LSE:AZM) received an exclusive global license to the manufacturing process for its ATL-101 mucositis product from the Katholieke Universiteit Leuven (Leuven, Belgium). AZM will pay the univer...